Kiniksa Pharmaceuticals International, plc
KNSA • NASDAQ
Kiniksa Pharmaceuticals International, plc is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sanj K. Patel, with a market cap of $3.5B.
CEOSanj K. Patel
Next Earnings
Upcoming earnings announcement for Kiniksa Pharmaceuticals International, plc
Date
Tuesday, April 28, 2026 (in 4 weeks)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.21
Revenue Estimate
$205.7M
Earnings History
Past 12 earnings reports for Kiniksa Pharmaceuticals International, plc
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 24, 2026 | Q4 2025 | $0.17Est: $0.35 | -51.4% | $202.1MEst: $200.9M | +0.6% |  10-K |
| Oct 28, 2025 | Q3 2025 | $0.23Est: $0.35 | -34.3% | $180.9MEst: $166.8M | +8.4% | 10-Q |
| Jul 29, 2025 | Q2 2025 | $0.23Est: $0.21 | +9.5% | $156.8MEst: $145.2M | +8.0% | 10-Q |
| Apr 29, 2025 | Q1 2025 | $0.11Est: $0.28 | -60.7% | $137.8MEst: $131.7M | +4.6% | 10-Q |
| Feb 25, 2025 | Q4 2024 | -$0.12Est: $0.13 | -192.3% | $122.5MEst: $123.4M | -0.7% | 10-K |
| Oct 29, 2024 | Q3 2024 | -$0.18Est: $0.03 | -700.0% | $112.2MEst: $111.5M | +0.6% | 10-Q |
| Jul 23, 2024 | Q2 2024 | -$0.06Est: -$0.07 | +14.3% | $108.6MEst: $92.3M | +17.7% | 10-Q |
| Apr 23, 2024 | Q1 2024 | -$0.25Est: -$0.16 | -56.3% | $79.9MEst: $78.5M | +1.8% | 10-Q |
| Feb 28, 2024 | Q4 2023 | $0.35Est: -$0.14 | +350.0% | $83.4MEst: $72.0M | +15.8% | 10-K |
| Oct 31, 2023 | Q3 2023 | -$0.20Est: -$0.17 | -17.6% | $67.0MEst: $64.5M | +4.0% | — |
| Jul 25, 2023 | Q2 2023 | -$0.02Est: -$0.17 | +88.2% | $71.5MEst: $52.2M | +36.9% | 10-Q |
| May 2, 2023 | Q1 2023 | -$0.18Est: -$0.21 | +14.3% | $48.3MEst: $46.6M | +3.8% | — |